<乌鸦传媒>Why the Atypical Symptoms in the Latest Monkeypox Cases? Experts agree these cases are unusual, but not necessarily a concern for viral mutation May 27, 2022
<乌鸦传媒>Oral Retinoid May Ease Painful Skin Reactions to Anticancer Therapy Preliminary data on acitretin therapy are promising May 11, 2022
<乌鸦传媒>In Lupus, 'Normal-Appearing' Skin Is Not Normal Groundwork for inflammation laid before lesions develop Apr 27, 2022
<乌鸦传媒>Testing for Th/To Antibodies May Help in Scleroderma Management Test identifies patients at high risk for pulmonary hypertension Apr 25, 2022
<乌鸦传媒>FDA OKs New Topical for Inflammatory Rosacea Almost half of patients clear of lesions or nearly so with benzoyl peroxide 5% cream (Epsolay) Apr 25, 2022
<乌鸦传媒>Smoker's Painless Skin Nodules Flag a Fatal Diagnosis Skin metastasis was the first sign for the otherwise asymptomatic patient Apr 04, 2022
<乌鸦传媒>First Topical Therapy for Facial Angiofibroma Nabs FDA Approval New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
<乌鸦传媒>Chronic Spontaneous Urticaria Responds Quickly to BTK Inhibitor AAD data also promising for therapies in psoriasis, pyoderma gangrenosum Mar 31, 2022
<乌鸦传媒>Meta-Analysis of Atopic Dermatitis Drugs Favors Two JAK Inhibitors Small advantages for abrocitinib, upadacitinib, but data still accumulating for all the players Mar 30, 2022
<乌鸦传媒>Toward More Uniform Methotrexate Dosing in Psoriasis International expert group urges common standards Mar 30, 2022
<乌鸦传媒>Jada Pinkett Smith's Alopecia The condition at the center of this year's Academy Awards drama Mar 29, 2022
<乌鸦传媒>Significant Improvement in Vitiligo With JAK Inhibitor Therapy Durable improvement in pigmentation with topical ruxolitinib, oral ritlecitinib Mar 29, 2022
<乌鸦传媒>Targeted Antibody Provides Significant Relief From Itchy Nodular Condition Dupilumab reduces itch, lesion count in first phase III trial for prurigo nodularis Mar 28, 2022
<乌鸦传媒>Dramatic, Durable Hair Growth With Oral JAK Inhibitor Oral baricitinib superior to placebo at 36 weeks in BRAVE-AA1 and BRAVE-AA2 trials Mar 27, 2022
<乌鸦传媒>Clinic-Based Hidradenitis Suppurativa Surgery Gets High Marks From Patients High satisfaction after three-fourths of procedures, despite frequent recurrences Mar 17, 2022
<乌鸦传媒>FDA Warns on Using Surgical Device for Aesthetic Skin Procedures Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
<乌鸦传媒>Predicting Treatment Response in Inflammatory Muscle Disorders Swedish registry study elicits factors associated with improvement Feb 16, 2022
<乌鸦传媒>Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosis Clinicians consider many differentials Feb 14, 2022
<乌鸦传媒>Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
<乌鸦传媒>Hair Loss Drugs Ranked in Order of Efficacy Meta-analysis attempts a head-to-head comparison Feb 07, 2022
<乌鸦传媒>Evidence Begins to Gel for Atopic Dermatitis, Multiple Comorbid Conditions Atopic, metabolic, cardiovascular, and mental health conditions cited in guideline update Feb 02, 2022
<乌鸦传媒>Six Medical 乌鸦传媒 With the Highest Hourly Wages Plastic and orthopedic surgery top the list Jan 27, 2022
<乌鸦传媒>Psoriasis Patients, Docs Want to Do More to Prevent Heart Problems Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
<乌鸦传媒>FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitis Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
<乌鸦传媒>IL-13 Inhibitor Approved for Adults With Atopic Dermatitis Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
<乌鸦传媒>Doc Fired After Standing Up to Private Equity; RFK Jr.'s Anti-Vax Machine This past week in healthcare investigations Dec 22, 2021
<乌鸦传媒>Think TikTok Is Smarter Than Me? Then I'm Not the Right Doctor for You Modern times have fundamentally altered the landscape of healthcare Nov 30, 2021
<乌鸦传媒>Signs of Relief From 'Therapeutic Drought' in Atopic Dermatitis Encouraging results from pipeline agents targeting T乌鸦传媒-specific inflammation Nov 09, 2021
<乌鸦传媒>Could This Biologic Drug Work in Patients Lacking Its Target? Bizarre finding with omalizumab Nov 07, 2021
<乌鸦传媒>Dramatic Responses in Cutaneous Sarcoidosis With JAK Inhibitor More than 80% reduction in disease activity in case series of tofacitinib treatment Nov 07, 2021
<乌鸦传媒>Substantial Improvement in Vitiligo With Topical JAK Inhibitor About 30% of patients had 75% clearance after 6 months, half had 50% clearance Nov 06, 2021
<乌鸦传媒>Early Success With New Target in Atopic Dermatitis Inhibition of T乌鸦传媒-related inflammation leads to rapid improvement in disease activity Nov 05, 2021
<乌鸦传媒>Topical PDE4 Inhibitor Impresses in Trial of Seborrheic Dermatitis Rapid, persistent improvement in body surface area, itch, other symptoms with roflumilast Nov 04, 2021
<乌鸦传媒>Botox Doc's License Suspended Over Breast, Penis Enhancement Harms One patient allegedly required two surgeries to fix penile enhancement gone wrong Oct 21, 2021
<乌鸦传媒>FDA to Make Isotretinoin Prescribing Gender Neutral Revision to risk management program dissociates gender from reproductive categories Oct 18, 2021
<乌鸦传媒>Is Private Equity a Dangerous Employer? Firms' investments in healthcare continue to expand, at what cost? Oct 14, 2021
<乌鸦传媒>FDA Warns on Needle-Free Injection Devices for Facial Fillers Serious injuries and "irreversible" harm to skin, lips, and eyes reported with unapproved devices Oct 08, 2021
<乌鸦传媒>FDA Issues Orders Clarifying Rules for Marketing Sunscreens But more studies on sunscreen chemicals are still needed, advocacy group says Sep 24, 2021
<乌鸦传媒>FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis Significant skin clearance, reduced itch in majority of patients treated with ruxolitinib cream Sep 22, 2021
